Merger Notification - Announcement according to § 10 Cartel Act
Merz Asset Management Holding GmbH & Co. KG; Walt Luxco S.à r.l.; Merz Consumer Care Austria GmbH; Dr. Kleine Pharma GmbH
BWB/Z-6745
On 17.10.2024 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
The Merz Group and the private equity investor Oakley Capital intend to establish a German company in which the two parties will each contribute companies with existing business activities,
namely the Merz Lifecare Group and the WindStar Group. Following the implementation of the proposed transaction, it is intended that Merz Group will indirectly hold sole control and the majority
of the shares in the new German company to be founded. The remaining shares will be indirectly held by the private equity investor Oakley Capital. The proposed transaction concerns the distribu-
tion of health and cosmetic products.
ÖNACE code: Manufacture of pharmaceutical preparations.
C - MANUFACTURING
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 28.11.2024.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
On 07.11.2024 the applicant requested the extension of the deadline for the submission of an application for examination by two weeks, pursuant to § 11 (1a) Cartel Act. The deadline for the submission of an application for examinations by the administrative authorities is extended by two weeks, thus ending on 28.11.2024.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 29.11.2024 .